Associated Papers
Chronic neutrophilic leukemia and atypical chronic myeloid leukemia: 2024 update on diagnosis, genetics, risk stratification, and management.
Szuber N et al.
American Journal of Hematology, 2024
Mutational landscape of cancer-driver genes across human cancers.
Sinkala M
Scientific Reports, 2023
Postazacitidine clone size predicts long-term outcome of patients with myelodysplastic syndromes and related myeloid neoplasms.
Nannya Y et al.
Blood Advances, 2023
Genomic landscape of patients with FLT3-mutated acute myeloid leukemia (AML) treated within the CALGB 10603/RATIFY trial.
Jahn N et al.
Leukemia, 2022
Chronic neutrophilic leukemia complicated with monoclonal gammopathy of undetermined significance: A case report and literature review.
Gao JP et al.
Journal of Clinical Laboratory Analysis, 2022
Distinct genomic landscape of Chinese pediatric acute myeloid leukemia impacts clinical risk classification.
Liu T et al.
Nature Communications, 2022
Analysis of gene mutation characteristics in patients with chronic neutrophilic leukaemia.
Yin B et al.
Hematology (amsterdam, Netherlands), 2019
CSF3R mutations were associated with an unfavorable prognosis in patients with acute myeloid leukemia with CEBPA double mutations.
Su L et al.
Annals of Hematology, 2019
A Novel Germline Variant in CSF3R Reduces N-Glycosylation and Exerts Potent Oncogenic Effects in Leukemia.
Spiciarich DR et al.
Cancer Research, 2018
Integrative omics analyses broaden treatment targets in human cancer.
Sengupta S et al.
Genome Medicine, 2018
Chronic neutrophilic leukemia: new science and new diagnostic criteria.
Szuber N et al.
Blood Cancer Journal, 2018
Characterization of the leukemogenic potential of distal cytoplasmic CSF3R truncation and missense mutations.
Zhang H et al.
Leukemia, 2017
CSF3R mutations have a high degree of overlap with CEBPA mutations in pediatric AML.
Maxson JE et al.
Blood, 2016
The Colony-Stimulating Factor 3 Receptor T640N Mutation Is Oncogenic, Sensitive to JAK Inhibition, and Mimics T618I.
Maxson JE et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research, 2016
Chronic neutrophilic leukemia: a clinical perspective.
Menezes J et al.
Oncotargets and Therapy, 2015
Ligand independence of the T618I mutation in the colony-stimulating factor 3 receptor (CSF3R) protein results from loss of O-linked glycosylation and increased receptor dimerization.
Maxson JE et al.
The Journal of Biological Chemistry, 2014
Oncogenic CSF3R mutations in chronic neutrophilic leukemia and atypical CML.
Maxson JE et al.
The New England Journal of Medicine, 2013